Cargando…

Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery

High-grade serous epithelial ovarian carcinoma (HGSOC) is an immunogenic tumor with a unique tumor microenvironment (TME) that extends to the peritoneal cavity. The immunosuppressive nature of TME imposes the major challenge to develop effective treatment options for HGSOC. Interaction of immune cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Pavan, Ranmale, Samruddhi, Tongaonkar, Hemant, Mania-Pramanik, Jayanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784879/
https://www.ncbi.nlm.nih.gov/pubmed/36560531
http://dx.doi.org/10.3390/vaccines10122121
_version_ 1784857916717662208
author Kumar, Pavan
Ranmale, Samruddhi
Tongaonkar, Hemant
Mania-Pramanik, Jayanti
author_facet Kumar, Pavan
Ranmale, Samruddhi
Tongaonkar, Hemant
Mania-Pramanik, Jayanti
author_sort Kumar, Pavan
collection PubMed
description High-grade serous epithelial ovarian carcinoma (HGSOC) is an immunogenic tumor with a unique tumor microenvironment (TME) that extends to the peritoneal cavity. The immunosuppressive nature of TME imposes the major challenge to develop effective treatment options for HGSOC. Interaction of immune cells in TME is an important factor. Hence, a better understanding of immune profile of TME may be required for exploring alternative treatment options. Immune profiling of peritoneal fluid (PF), tumor specimens, and blood were carried out using flowcytometry, ELISA, and Procartaplex immunoassay. The frequency of CD56(Bright)NK cells and expression of functional receptors were reduced in PF. Increased activating NKp46+CD56(Dim)NK cells may indicate differential antitumor response in PF. Functional receptors on NK, NKT-like and T cells were reduced more drastically in tumor specimens. Soluble ligands MIC-B and PVR were reduced, whereas B7-H6 was increased in PF. Dissemination of tumor cells contributes to soluble ligands in PF. A differential cytokine profile was found in serum and PF as IL-2, IL-8, IL-15, IL-27, IFN-γ, and GM-CSF were elevated specifically in PF. In conclusion, the differential immune profile and correlation of soluble parameters and NK cell receptors with chemo response score may add knowledge to understand anti-tumor immune response to develop effective treatment modality.
format Online
Article
Text
id pubmed-9784879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97848792022-12-24 Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery Kumar, Pavan Ranmale, Samruddhi Tongaonkar, Hemant Mania-Pramanik, Jayanti Vaccines (Basel) Article High-grade serous epithelial ovarian carcinoma (HGSOC) is an immunogenic tumor with a unique tumor microenvironment (TME) that extends to the peritoneal cavity. The immunosuppressive nature of TME imposes the major challenge to develop effective treatment options for HGSOC. Interaction of immune cells in TME is an important factor. Hence, a better understanding of immune profile of TME may be required for exploring alternative treatment options. Immune profiling of peritoneal fluid (PF), tumor specimens, and blood were carried out using flowcytometry, ELISA, and Procartaplex immunoassay. The frequency of CD56(Bright)NK cells and expression of functional receptors were reduced in PF. Increased activating NKp46+CD56(Dim)NK cells may indicate differential antitumor response in PF. Functional receptors on NK, NKT-like and T cells were reduced more drastically in tumor specimens. Soluble ligands MIC-B and PVR were reduced, whereas B7-H6 was increased in PF. Dissemination of tumor cells contributes to soluble ligands in PF. A differential cytokine profile was found in serum and PF as IL-2, IL-8, IL-15, IL-27, IFN-γ, and GM-CSF were elevated specifically in PF. In conclusion, the differential immune profile and correlation of soluble parameters and NK cell receptors with chemo response score may add knowledge to understand anti-tumor immune response to develop effective treatment modality. MDPI 2022-12-12 /pmc/articles/PMC9784879/ /pubmed/36560531 http://dx.doi.org/10.3390/vaccines10122121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kumar, Pavan
Ranmale, Samruddhi
Tongaonkar, Hemant
Mania-Pramanik, Jayanti
Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery
title Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery
title_full Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery
title_fullStr Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery
title_full_unstemmed Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery
title_short Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery
title_sort immune profile of blood, tissue and peritoneal fluid: a comparative study in high grade serous epithelial ovarian cancer patients at interval debulking surgery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784879/
https://www.ncbi.nlm.nih.gov/pubmed/36560531
http://dx.doi.org/10.3390/vaccines10122121
work_keys_str_mv AT kumarpavan immuneprofileofbloodtissueandperitonealfluidacomparativestudyinhighgradeserousepithelialovariancancerpatientsatintervaldebulkingsurgery
AT ranmalesamruddhi immuneprofileofbloodtissueandperitonealfluidacomparativestudyinhighgradeserousepithelialovariancancerpatientsatintervaldebulkingsurgery
AT tongaonkarhemant immuneprofileofbloodtissueandperitonealfluidacomparativestudyinhighgradeserousepithelialovariancancerpatientsatintervaldebulkingsurgery
AT maniapramanikjayanti immuneprofileofbloodtissueandperitonealfluidacomparativestudyinhighgradeserousepithelialovariancancerpatientsatintervaldebulkingsurgery